CA-XPRIZE
22.12.2020 22:02:12 CET | Business Wire | Press release
XPRIZE , a nonprofit organization that uses global competitions to crowdsource solutions to some of the world’s biggest challenges, is pleased to announce that, following last week’s pitch slam, Luminosity Lab from the United States has been named the grand prize winner of the organization’s Next-Gen Mask Challenge . Selected by the competition’s panel of judges, which included a diverse set of industry professionals and executives, Luminosity Lab was chosen from the other finalists for their mask’s design, x-factor of style, early assessments of accessibility and functionality. The winning team is student-led and developed the FloeMask, which uses a bifurcated filtration chamber to achieve filtration and breathability for use everyday and during exercise, diverting heat from the wearer’s face.
Luminosity Lab is from Arizona State University in Tempe, Arizona and includes Nikhil Dave (age 20), Tarun Suresh (age 22), Katie Sue Pascavis (age 19), John Patterson (age 22) and Jerina Winter Gabriel (age 20). The team of five felt compelled to spring into action after witnessing the devastating impact the COVID-19 pandemic had on their Arizona community. Within the first few months of the crisis, the students behind Luminosity Lab helped develop the PPE Response Network , which was responsible for crowdsourcing 3D printers across Arizona to create and distribute over 15,000 units of PPE to clinics facing shortages, and designed two patent-pending technologies capable of sterilizing disposable N95 masks for reuse. Their participation in the XPRIZE Next-Gen Mask Challenge was driven by their desire to design a better way to protect those that choose to wear a mask and help communities around the world. The winning team will receive a total prize purse of $500,000, exiting the competition with the network and knowledge needed to further refine their prototype, and ensure it meets filtration requirements, should they decide to bring their design to market in the future.
In addition, two teams, Polair from John Hopkins University in Maryland and Naija Force from Abuja, Nigeria, have been named runners up in the competition and will split $500,000 as the two category winners. Team Polair, composed of 25 engineering undergraduates, was chosen as the Future Forward Award winner and won $250,000 for their prototype’s modular design which allows users to swap out mask bodies and choose a filter based on their environment. Naija Force won $250,000 as the winner of the ‘Mass’k Appeal Award for the transparent face mask they designed, which features straps that can be worn over the ear or on-head. These teams will now begin the process of refining their mask to ensure they meet key filtration metrics.
Launched this July amid the COVID-19 pandemic, the XPRIZE Next-Gen Mask Challenge, sponsored by Salesforce CEO Marc Benioff and CNBC host Jim Cramer, asked young inventors between the ages of 15-24 to develop the next generation of protective face masks. Throughout the competition, teams had the opportunity to interact with the challenge’s seven industry partners, who lent their expertise to contestants, including: 3M , Autodesk Inc. , Bryan Cave Leighton Paisner LLP, Honeywell , Lydall, National Association of Manufacturers (NAM) and Under Armour . The competition, which received record entries with 992 teams from 76 countries expressing interest within two months, encouraged teams to design a face mask that overcame at least five of the top ten barriers to mask-wearing, as defined by an XPRIZE-conducted survey. Those common barriers to use included: fogging of glasses, getting too hot, being uncomfortable, causing breathing difficulties, making conversations challenging, prohibiting exercise while wearing, causing pain or not fitting properly, blocking facial expressions, preventing eating or drinking, not being eco-friendly, looking ugly or boring, and difficulty acquiring.
Winning teams were chosen, and final judging was conducted by a panel of experts that included:
- Ashish Diwanji, president of Lydall Performance Materials
- Brian Hovey, vice president, marketing and commercial excellence at Honeywell
- Denise Rutherford, senior vice president - corporate affairs at 3M
- Dr. Erik Viirre, professor at University of California San Diego’s Department of Neurosciences and director at the Arthur C. Clarke Center for Human Imagination
- Garret Gerson, CEO of Calamigos Ranch
- Heather Hughes, group vice president/general merchandise manager seasonal, general merchandise and photo at Walgreens
- June Ambrose, award-winning creative director, author, costume designer and celebrity stylist
- Dr. Kimberly Prather, professor and distinguished chair in atmospheric chemistry at University of California San Diego
- Summer Chamblin, Gen-Z entrepreneur, content creator and daughter of June Ambrose
- Suzanne DiBianca, chief impact officer at Salesforce
Additionally, XPRIZE is pleased to share that team Novus has won the $10,000 People’s Vote Bonus Award which was open to all Next-Gen Mask Challenge top twenty-five teams. The social media-based competition asked teams to defend their design and share their best elevator pitch with their friends, families and followers on social media. Team Novus, based in India, received the most engagement across their social media channels with over 3,000 reactions and interactions on the posts that featured their elevator pitch explaining their design.
"We are absolutely thrilled to be the winners of the Next-Gen Mask Challenge, and are extremely grateful to XPRIZE and all of the incredible sponsors and partners of this event,” said Nikhil Dave of Luminosity Lab. “Since COVID-19 first hit our community in March, we have sought out every way in which we can help - whether it be through crowdsourcing 3D-printed PPE, developing sterilization systems for N95 masks, or even designing our own next-generation mask. We can’t wait to continue pushing to support our global community in every way possible and are absolutely thrilled to have the opportunity to continue this work with the support and encouragement of XPRIZE.”
“We congratulate the winners of the competition,” said Jim Cramer, the host of Mad Money on CNBC. “When we started this journey, we wanted to create awareness among young people for the need to wear masks. We are gratified to have so many entries from around the world. Now the hard work begins as our young champions set out to develop these masks into ones that will be demonstrated to be effective and can be worn around the globe to try to stop the spread of COVID-19.”
“Wearing a mask is one of the most important steps we can take in defeating this pandemic,” said Marc Benioff. “The XPRIZE Next-Gen Mask Challenge has unleashed the talent of some of the most incredible young innovators who are eager to help create a healthier future for us all.”
Teams will receive their winnings within sixty days and will work independently as they choose to finalize their prototypes utilizing the insight provided throughout the competition and final feedback from the judges. Those interested in following along can do so at xprize.org/mask , theluminositylab.com , teampolair.com and teamnaijaforce.com.ng . For additional information on XPRIZE, please visit www.xprize.org .
ABOUT XPRIZE
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE and the $5 Million XPRIZE Rapid Reskilling. For more information, visit xprize.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201222005657/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
